Biotech
Daiwa VC fund manager DCI Partners launches $135M fund to accelerate drug discovery
Tokyo-based DCI Partners, a venture fund manager of Daiwa Securities Group, has announced the launch of Daiwa Taiwan-Japan BioVenture Investment Limited Partnership II, a $135 million (JPY 14 billion) investment fund intended for drug discovery.
Singapore food startup gets funding for its ‘healthy’ ice cream
Will consumers scream for low-fat ice cream?
